The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Histone methyltransferases in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Bernard, D., Martínez-Leal, J. F., Rizzo, S., Martínez, D., Hudson, D. L., Visakorpi, T., Peters, G. G., Carnero, A., Beach, D., & Gil, J. (2005) · Oncogene · doi:10.1038/sj.onc.1208735 · Cited by 151
RetractedHigh-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845
The fundamental role of epigenetic events in cancer
Jones, P. A., & Baylin, S. B. (2002) · Nature Reviews Genetics · doi:10.1038/nrg816 · Cited by 5,648
Jones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,057
Fraga, M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Haydon, C., Ropero, S., Petrie, K., et al. (2005) · Nature Genetics · doi:10.1038/ng1531 · Cited by 1,923
Protein Arginine Methylation in Mammals: Who, What, and Why
Bedford, M. T., & Clarke, S. G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.013 · Cited by 1,792
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Weber, M., Davies, J. J., Wittig, D., Oakeley, E. J., Haase, M., Lam, W. L., & Schübeler, D. (2005) · Nature Genetics · doi:10.1038/ng1598 · Cited by 1,754
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Induction of tumors in mice by genomic hypomethylation
Gaudet, F., Hodgson, J. G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J. W., Leonhardt, H., & Jaenisch, R. (2003) · Science · doi:10.1126/science.1083558 · Cited by 1,499 · cited 1×
“Tumors re also induced in mice with genomic DNA hypomethylation [47], tressing the potential importance of histone and DNA methylaion marks for genome integrity.”
BackgroundBmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation
Molofsky, A. V., Pardal, R., Iwashita, T., Park, I.-K., Clarke, M. F., & Morrison, S. J. (2003) · Nature · doi:10.1038/nature02060 · Cited by 1,310
Polycomb silencers control cell fate, development and cancer
Sparmann, A., & van Lohuizen, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1991 · Cited by 1,303
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
Self-citationEpigenetic Regulation of Cellular Memory by the Polycomb and Trithorax Group Proteins
Ringrose, L., & Paro, R. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.091907 · Cited by 1,077
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF
Jacobs, J. J. L., Scheijen, B., Voncken, J.-W., Kieboom, K., Berns, A., & van Lohuizen, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2678 · Cited by 1,065
Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer
Varambally, S., Cao, Q., Mani, R.-S., Shankar, S., Wang, X., Ateeq, B., Laxman, B., Cao, X., Jing, X., Ramnarayanan, K., et al. (2008) · Science · doi:10.1126/science.1165395 · Cited by 1,052
Shen, X., Liu, Y., Hsu, Y.-J., Fujiwara, Y., Kim, J., Mao, X., Yuan, G.-C., & Orkin, S. H. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.016 · Cited by 1,021
The Polycomb-Group Gene Ezh2 Is Required for Early Mouse Development
O'Carroll, D., Erhardt, S., Pagani, M., Barton, S. C., Surani, M. A., & Jenuwein, T. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.13.4330-4336.2001 · Cited by 912
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895 · cited 1×
“To date, only a few specific [130,131] and unspecific [132,133] inhibitors of HMTs are available, but larger screening efforts are in progress and hopefully will identify additional inhibitors with clinical potential.”
BackgroundAltered Hox expression and segmental identity in Mll-mutant mice
Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Nature · doi:10.1038/378505a0 · Cited by 875
Reversal of H3K9me2 by a Small-Molecule Inhibitor for the G9a Histone Methyltransferase
Kubicek, S., O'Sullivan, R. J., August, E. M., Hickey, E. R., Zhang, Q., Teodoro, M. L., Rea, S., Mechtler, K., Kowalski, J. A., Homon, C. A., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.01.017 · Cited by 859
Bachmann, I. M., Halvorsen, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P., & Akslen, L. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5180 · Cited by 851
Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Mönch, K., Minucci, S., Porse, B. T., Marine, J.-C., et al. (2007) · Genes & Development · doi:10.1101/gad.415507 · Cited by 850
Self-citationRegulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 2×
“endently to various positive and negative signals [102], the PcG roteins may allow coordinated repression of the locus [102,103].”
BackgroundhDOT1L Links Histone Methylation to Leukemogenesis
Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 804
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.349 · Cited by 784
van der Lugt, N. M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., & van Lohuizen, M. (1994) · Genes & Development · doi:10.1101/gad.8.7.757 · Cited by 781
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F. P., Li, M., Yagyu, R., & Nakamura, Y. (2004) · Nature Cell Biology · doi:10.1038/ncb1151 · Cited by 731
The Polycomb Group Protein Suz12 Is Required for Embryonic Stem Cell Differentiation
Pasini, D., Bracken, A. P., Hansen, J. B., Capillo, M., & Helin, K. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01432-06 · Cited by 696
Self-citationKrogan, N. J., Kim, M., Tong, A., Golshani, A., Cagney, G., Canadien, V., Richards, D. P., Beattie, B. K., Emili, A., Boone, C., et al. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4207-4218.2003 · Cited by 686
Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease
Cloos, P. A. C., Christensen, J., Agger, K., & Helin, K. (2008) · Genes & Development · doi:10.1101/gad.1652908 · Cited by 669
Self-citationHaploinsufficiency of NSD1 causes Sotos syndrome
Kurotaki, N., Imaizumi, K., Harada, N., Masuno, M., Kondoh, T., Nagai, T., Ohashi, H., Naritomi, K., Tsukahara, M., Makita, Y., et al. (2002) · Nature Genetics · doi:10.1038/ng863 · Cited by 644
Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Miranda, T. B., Cortez, C. C., Yoo, C. B., Liang, G., Abe, M., Kelly, T. K., Marquez, V. E., & Jones, P. A. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0013 · Cited by 596
Molofsky, A. V., He, S., Bydon, M., Morrison, S. J., & Pardal, R. (2005) · Genes & Development · doi:10.1101/gad.1299505 · Cited by 588
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Cao, Q., Yu, J., Dhanasekaran, S. M., Kim, J. H., Mani, R.-S., Tomlins, S. A., Mehra, R., Laxman, B., Cao, X., Yu, J., et al. (2008) · Oncogene · doi:10.1038/onc.2008.333 · Cited by 583
Chesi, M., Nardini, E., Lim, R. S. C., Smith, K. D., Kuehl, W. M., & Bergsagel, P. L. (1998) · Blood · doi:10.1182/blood.v92.9.3025 · Cited by 572
Strahl, B. D., Grant, P. A., Briggs, S. D., Sun, Z.-W., Bone, J. R., Caldwell, J. A., Mollah, S., Cook, R. G., Shabanowitz, J., Hunt, D. F., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1298-1306.2002 · Cited by 562
H3K79 Methylation Profiles Define Murine and Human MLL-AF4 Leukemias
Krivtsov, A. V., Feng, Z., Lemieux, M. E., Faber, J., Vempati, S., Sinha, A. U., Xia, X., Jesneck, J., Bracken, A. P., Silverman, L. B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.001 · Cited by 550
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 546
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Bracken, A. P., & Helin, K. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2736 · Cited by 523
Self-citationIdentification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9
Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E., & Imhof, A. (2005) · Nature Chemical Biology · doi:10.1038/nchembio721 · Cited by 521
Haupt, Y., Alexander, W. S., Barri, G., Peter Klinken, S., & Adams, J. M. (1991) · Cell · doi:10.1016/0092-8674(91)90383-a · Cited by 513
Sauvageau, G., Lansdorp, P. M., Eaves, C. J., Hogge, D. E., Dragowska, W. H., Reid, D. S., Largman, C., Lawrence, H. J., & Humphries, R. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12223 · Cited by 497
Bmi1 regulates mitochondrial function and the DNA damage response pathway
Liu, J., Cao, L., Chen, J., Song, S., Lee, I. H., Quijano, C., Liu, H., Keyvanfar, K., Chen, H., Cao, L.-Y., et al. (2009) · Nature · doi:10.1038/nature08040 · Cited by 474
Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
Wang, G. G., Song, J., Wang, Z., Dormann, H. L., Casadio, F., Li, H., Luo, J.-L., Patel, D. J., & Allis, C. D. (2009) · Nature · doi:10.1038/nature08036 · Cited by 438
NUP98–NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis
Wang, G. G., Cai, L., Pasillas, M. P., & Kamps, M. P. (2007) · Nature Cell Biology · doi:10.1038/ncb1608 · Cited by 437
Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor
Herranz, N., Pasini, D., Díaz, V. M., Francí, C., Gutierrez, A., Dave, N., Escrivà, M., Hernandez-Muñoz, I., Di Croce, L., Helin, K., et al. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00323-08 · Cited by 437
Self-citationTransformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
Ayton, P. M., & Cleary, M. L. (2003) · Genes & Development · doi:10.1101/gad.1111603 · Cited by 436
Lee, J., Son, M. J., Woolard, K., Donin, N. M., Li, A., Cheng, C. H., Kotliarova, S., Kotliarov, Y., Walling, J., Ahn, S., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2007.12.005 · Cited by 429
Northcott, P. A., Nakahara, Y., Wu, X., Feuk, L., Ellison, D. W., Croul, S., Mack, S., Kongkham, P. N., Peacock, J., Dubuc, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.336 · Cited by 412
Phosphorylation of RNA polymerase II CTD regulates H3 methylation in yeast
Xiao, T., Hall, H., Kizer, K. O., Shibata, Y., Hall, M. C., Borchers, C. H., & Strahl, B. D. (2003) · Genes & Development · doi:10.1101/gad.1055503 · Cited by 411
A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification
Mueller, D., Bach, C., Zeisig, D., Garcia-Cuellar, M.-P., Monroe, S., Sreekumar, A., Zhou, R., Nesvizhskii, A., Chinnaiyan, A., Hess, J. L., et al. (2007) · Blood · doi:10.1182/blood-2007-05-090514 · Cited by 397
MYC stimulates EZH2 expression by repression of its negative regulator miR-26a
Sander, S., Bullinger, L., Klapproth, K., Fiedler, K., Kestler, H. A., Barth, T. F. E., Möller, P., Stilgenbauer, S., Pollack, J. R., & Wirth, T. (2008) · Blood · doi:10.1182/blood-2008-03-147645 · Cited by 395
Kleefstra, T., Brunner, H. G., Amiel, J., Oudakker, A. R., Nillesen, W. M., Magee, A., Geneviève, D., Cormier-Daire, V., van Esch, H., Fryns, J.-P., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/505693 · Cited by 393
Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors
Koontz, J. I., Soreng, A. L., Nucci, M., Kuo, F. C., Pauwels, P., van den Berghe, H., Cin, P. D., Fletcher, J. A., & Sklar, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101132598 · Cited by 390
A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf–Hirschhorn syndrome
Nimura, K., Ura, K., Shiratori, H., Ikawa, M., Okabe, M., Schwartz, R. J., & Kaneda, Y. (2009) · Nature · doi:10.1038/nature08086 · Cited by 373
Li, B., Howe, L., Anderson, S., Yates, J. R., & Workman, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212134200 · Cited by 371
Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma
Pasqualucci, L., Compagno, M., Houldsworth, J., Monti, S., Grunn, A., Nandula, S. V., Aster, J. C., Murty, V. V., Shipp, M. A., & Dalla-Favera, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052204 · Cited by 370
Thorsteinsdottir, U., Mamo, A., Kroon, E., Jerome, L., Bijl, J., Lawrence, H. J., Humphries, K., & Sauvageau, G. (2002) · Blood · doi:10.1182/blood.v99.1.121 · Cited by 347
NSD1 is essential for early post-implantation development and has a catalytically active SET domain
Rayasam, G. V. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg288 · Cited by 342
Polycomb CBX7 has a unifying role in cellular lifespan.
Gil, J., Bernard, D., Martínez, D., & Beach, D. (2004) · Nature Cell Biology · doi:10.1038/ncb1077 · Cited by 341
Polycomb Repressive Complex 2 Is Dispensable for Maintenance of Embryonic Stem Cell Pluripotency
Chamberlain, S. J., Yee, D., & Magnuson, T. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0102 · Cited by 340
Tatton-Brown, K., Douglas, J., Coleman, K., Baujat, G., Cole, T. R. P., Das, S., Horn, D., Hughes, H. E., Temple, I. K., Faravelli, F., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/432082 · Cited by 338
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease
Ryu, H., Lee, J., Hagerty, S. W., Soh, B. Y., McAlpin, S. E., Cormier, K. A., Smith, K. M., & Ferrante, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606373103 · Cited by 325
Tebar, F., Bohlander, S. K., & Sorkin, A. (1999) · Molecular Biology of the Cell · doi:10.1091/mbc.10.8.2687 · Cited by 320
Oda, H., Okamoto, I., Murphy, N., Chu, J., Price, S. M., Shen, M. M., Torres-Padilla, M. E., Heard, E., & Reinberg, D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01768-08 · Cited by 319
Moreau, P., Facon, T., Leleu, X., Morineau, N., Huyghe, P., Harousseau, J.-L., Bataille, R., & Avet-Loiseau, H. (2002) · Blood · doi:10.1182/blood-2002-03-0749 · Cited by 317
Bruggeman, S. W. M., Valk-Lingbeek, M. E., van der Stoop, P. P. M., Jacobs, J. J. L., Kieboom, K., Tanger, E., Hulsman, D., Leung, C., Arsenijevic, Y., Marino, S., et al. (2005) · Genes & Development · doi:10.1101/gad.1299305 · Cited by 315
Stec, I., Wright, T. J., van Ommen, G.-J. B., de Boer, P. A. J., van Haeringen, A., Moorman, A. F. M., Altherr, M. R., & den Dunnen, J. T. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.7.1071 · Cited by 308
Jaju, R. J. (2001) · Blood · doi:10.1182/blood.v98.4.1264 · Cited by 303
Douglas, J., Hanks, S., Temple, I. K., Davies, S., Murray, A., Upadhyaya, M., Tomkins, S., Hughes, H. E., Trevor Cole, R. P., & Rahman, N. (2003) · The American Journal of Human Genetics · doi:10.1086/345647 · Cited by 301
Protein arginine-methyltransferase-dependent oncogenesis
Cheung, N., Chan, L. C., Thompson, A., Cleary, M. L., & So, C. W. E. (2007) · Nature Cell Biology · doi:10.1038/ncb1642 · Cited by 291
Low levels of miR‐92b/96 induce PRMT5 translation and H3R8/H4R3 methylation in mantle cell lymphoma
Pal, S., Baiocchi, R. A., Byrd, J. C., Grever, M. R., Jacob, S. T., & Sif, S. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601794 · Cited by 282
Mll Has a Critical Role in Fetal and Adult Hematopoietic Stem Cell Self-Renewal
McMahon, K. A., Hiew, S. Y.-L., Hadjur, S., Veiga-Fernandes, H., Menzel, U., Price, A. J., Kioussis, D., Williams, O., & Brady, H. J. M. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.07.002 · Cited by 273
Collett, K., Eide, G. E., Arnes, J., Stefansson, I. M., Eide, J., Braaten, A., Aas, T., Otte, A. P., & Akslen, L. A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1533 · Cited by 272
Enhanced SMYD3 expression is essential for the growth of breast cancer cells
Hamamoto, R., Silva, F. P., Tsuge, M., Nishidate, T., Katagiri, T., Nakamura, Y., & Furukawa, Y. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00146.x · Cited by 268
van Kemenade, F. J., Raaphorst, F. M., Blokzijl, T., Fieret, E., Hamer, K. M., Satijn, D. P. E., Otte, A. P., & Meijer, C. J. L. M. (2001) · Blood · doi:10.1182/blood.v97.12.3896 · Cited by 266
Huang, N. (1998) · The EMBO Journal · doi:10.1093/emboj/17.12.3398 · Cited by 262
Wang, L., Pal, S., & Sif, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00923-08 · Cited by 259
Kleefstra, T., van Zelst-Stams, W. A., Nillesen, W. M., Cormier-Daire, V, Houge, G., Foulds, N., van Dooren, M., Willemsen, M. H., Pfundt, R., Turner, A., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062950 · Cited by 252
Role of the Polycomb Repressive Complex 2 in Acute Promyelocytic Leukemia
Villa, R., Pasini, D., Gutierrez, A., Morey, L., Occhionorelli, M., Viré, E., Nomdedeu, J. F., Jenuwein, T., Pelicci, P. G., Minucci, S., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.04.009 · Cited by 247
Self-citationClinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma
Sudo, T., Utsunomiya, T., Mimori, K., Nagahara, H., Ogawa, K., Inoue, H., Wakiyama, S., Fujita, H., Shirouzu, K., & Mori, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602531 · Cited by 243
Growth Disturbance in Fetal Liver Hematopoiesis of Mll-Mutant Mice
Yagi, H., Deguchi, K., Aono, A., Tani, Y., Kishimoto, T., & Komori, T. (1998) · Blood · doi:10.1182/blood.v92.1.108.413k11_108_117 · Cited by 238
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
Visser, H. P. J., Gunster, M. J., Kluin‐Nelemans, H. C., Manders, E. M. M., Raaphorst, F. M., Meijer, C. J. L. M., Willemze, R., & Otte, A. P. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.02641.x · Cited by 234
The emerging functions of histone demethylases
Agger, K., Christensen, J., Cloos, P. A., & Helin, K. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2007.12.003 · Cited by 231
Self-citationMutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas
Tam, W., Gomez, M., Chadburn, A., Lee, J. W., Chan, W. C., & Knowles, D. M. (2006) · Blood · doi:10.1182/blood-2005-09-3778 · Cited by 230
Van Vlierberghe, P., van Grotel, M., Tchinda, J., Lee, C., Beverloo, H. B., van der Spek, P. J., Stubbs, A., Cools, J., Nagata, K., Fornerod, M., et al. (2008) · Blood · doi:10.1182/blood-2007-09-111872 · Cited by 225
Yu, J., Cao, Q., Mehra, R., Laxman, B., Yu, J., Tomlins, S. A., Creighton, C. J., Dhanasekaran, S. M., Shen, R., Chen, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.016 · Cited by 223
Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias
Lawrence, H., Rozenfeld, S., Cruz, C., Matsukuma, K., Kwong, A., Kömüves, L., Buchberg, A., & Largman, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401578 · Cited by 222
Division of labor in Polycomb group repression
Levine, S. S., King, I. F. G., & Kingston, R. E. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.07.007 · Cited by 219
Steele-Perkins, G., Fang, W., Yang, X.-H., Van Gele, M., Carling, T., Gu, J., Buyse, I. M., Fletcher, J. A., Liu, J., Bronson, R., et al. (2001) · Genes & Development · doi:10.1101/gad.870101 · Cited by 208 · cited 2×
“M Diffuse B-cell lymphoma (DBCL) Knockout mice [158]”
BackgroundTerranova, R., Agherbi, H., Boned, A., Meresse, S., & Djabali, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507425103 · Cited by 208
Mechanisms of transcriptional repression by histone lysine methylation
Hublitz, P., Albert, M., Hfmpeters, A., Hublitz, P., Albert, M., & Peters, A. H. F. M. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082717ph · Cited by 207
Self-citationHong, H., Kao, C., Jeng, M., Eble, J. N., Koch, M. O., Gardner, T. A., Zhang, S., Li, L., Pan, C., Hu, Z., et al. (2004) · Cancer · doi:10.1002/cncr.20327 · Cited by 204
Marango, J., Shimoyama, M., Nishio, H., Meyer, J. A., Min, D.-J., Sirulnik, A., Martinez-Martinez, Y., Chesi, M., Bergsagel, P. L., Zhou, M.-M., et al. (2008) · Blood · doi:10.1182/blood-2007-06-092122 · Cited by 197
Kleefstra, T., Smidt, M., Banning, M. J. G., Oudakker, A. R., Van Esch, H., de Brouwer, A. P. M., Nillesen, W., Sistermans, E. A., Hamel, B. C. J., de Bruijn, D., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.028464 · Cited by 197
NUP98 is fused to the NSD3 gene in acute myeloid leukemia associated with t(8;11)(p11.2;p15)
Rosati, R., La Starza, R., Veronese, A., Aventin, A., Schwienbacher, C., Vallespi, T., Negrini, M., Martelli, M. F., & Mecucci, C. (2002) · Blood · doi:10.1182/blood.v99.10.3857 · Cited by 195
Increased Expression of the Polycomb Group Gene, EZH2, in Transitional Cell Carcinoma of the Bladder
Raman, J. D., Mongan, N. P., Tickoo, S. K., Boorjian, S. A., Scherr, D. S., & Gudas, L. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1047 · Cited by 193
Goulet, I., Gauvin, G., Boisvenue, S., & Côté, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704349200 · Cited by 189
Du, Y., Carling, T., Fang, W., Piao, Z. H., Sheu, J., & Huang, S. (2001) · PubMed · Cited by 189
Dietrich, N., Bracken, A. P., Trinh, E., Schjerling, C. K., Koseki, H., Rappsilber, J., Helin, K., & Hansen, K. H. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601632 · Cited by 187
Self-citationSantra, M., Zhan, F., Tian, E., Barlogie, B., & Shaughnessy, J. (2003) · Blood · doi:10.1182/blood-2002-09-2801 · Cited by 184
Keats, J. J., Maxwell, C. A., Taylor, B. J., Hendzel, M. J., Chesi, M., Bergsagel, P. L., Larratt, L. M., Mant, M. J., Reiman, T., Belch, A. R., et al. (2005) · Blood · doi:10.1182/blood-2004-09-3704 · Cited by 181
Leukaemic transformation by CALM–AF10 involves upregulation of Hoxa5 by hDOT1L
Okada, Y., Jiang, Q., Lemieux, M., Jeannotte, L., Su, L., & Zhang, Y. (2006) · Nature Cell Biology · doi:10.1038/ncb1464 · Cited by 179
Angrand, P.-O., Apiou, F., Stewart, A. F., Dutrillaux, B., Losson, R., & Chambon, P. (2001) · Genomics · doi:10.1006/geno.2001.6524 · Cited by 177
Candidate tumor suppressor RIZ is frequently involved in colorectal carcinogenesis
Chadwick, R. B., Jiang, G.-L., Bennington, G. A., Yuan, B., Johnson, C. K., Stevens, M. W., Niemann, T. H., Peltomaki, P., Huang, S., & de la Chapelle, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040579497 · Cited by 174
Majumder, S., Liu, Y., Ford, O. H., Mohler, J. L., & Whang, Y. E. (2006) · The Prostate · doi:10.1002/pros.20438 · Cited by 168
Nie, K., Gomez, M. F., Landgraf, P., García, J. F., Liu, Y., Tan, L. H. C., Chadburn, A., Tuschl, T., Knowles, D. M., & Tam, W. (2008) · American Journal Of Pathology · doi:10.2353/ajpath.2008.080009 · Cited by 167
Yang, X., Karuturi, R. K. M., Sun, F., Aau, M., Yu, K., Shao, R., Miller, L. D., Tan, P. B. O., & Yu, Q. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005011 · Cited by 164
Croonquist, P. A., & Van Ness, B. (2005) · Oncogene · doi:10.1038/sj.onc.1208771 · Cited by 162
Lauring, J. D., Abukhdeir, A. M., Konishi, H., Garay, J. P., Gustin, J. P., Wang, Q., Arceci, R. J., Matsui, W. H., & Park, B. H. (2007) · Blood · doi:10.1182/blood-2007-05-088674 · Cited by 162
Whitman, S. P., Liu, S., Vukosavljevic, T., Rush, L. J., Yu, L., Liu, C., Klisovic, M. I., Maharry, K. S., Guimond, M., Strout, M. P., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0204 · Cited by 153
Weikert, S., Christoph, F., Köllermann, J. W., Müller, M., Schrader, M. G., Miller, K., & Krause, H. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.16.2.349 · Cited by 151
Morey, L., Brenner, C., Fazi, F., Villa, R., Gutiérrez, A., Buschbeck, M., Nervi, C., Minucci, S., Fuks, F., & Croce, L. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00467-08 · Cited by 146
He, L., Yu, J., Liu, L., Buyse, I. M., Wang, M., Yang, Q. C., Nakagawara, A., Brodeur, G. M., Shi, Y. E., & Huang, S. (1998) · PubMed · Cited by 145
The PRC1 Polycomb group complex interacts with PLZF/RARA to mediate leukemic transformationPreprint
Boukarabila, H., Saurin, A. J., Batsché, É., Mossadegh‐Keller, N., van Lohuizen, M., Otte, A. P., Pradel, J., Muchardt, C., Sieweke, M. H., & Duprez, E. (2009) · Genes & Development · doi:10.1101/gad.512009 · Cited by 138
Fujii, S., & Ochiai, A. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00743.x · Cited by 136
Gene Amplification and Overexpression of PRDM14 in Breast Cancers
Nishikawa, N., Toyota, M., Suzuki, H., Honma, T., Fujikane, T., Ohmura, T., Nishidate, T., Ohe-Toyota, M., Maruyama, R., Sonoda, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4111 · Cited by 129
Saigo, K., Yoshida, K., Ikeda, R., Sakamoto, Y., Murakami, Y., Urashima, T., Asano, T., Kenmochi, T., & Inoue, I. (2008) · Human Mutation · doi:10.1002/humu.20701 · Cited by 128
Dorrance, A. M., Liu, S., Yuan, W., Becknell, B., Arnoczky, K. J., Guimond, M., Strout, M. P., Feng, L., Nakamura, T., Yu, L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25546 · Cited by 128
Brito, J. L. R., Walker, B. A., Jenner, M. W., Dickens, N. J., Brown, N. J. M., Ross, F. M., Avramidou, A., Irving, J. A. E., Gonzalez, D., Davies, F. E., et al. (2008) · Haematologica · doi:10.3324/haematol.13426 · Cited by 124
Beke, L., Nuytten, M., Eynde, A. V., Beullens, M., & Bollen, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210248 · Cited by 121
Tsuge, M., Hamamoto, R., Pittella-Silva, F., Ohnishi, Y., Chayama, K., Kamatani, N., Furukawa, Y., & Nakamura, Y. (2005) · Nature Genetics · doi:10.1038/ng1638 · Cited by 117
PRDM5 is silenced in human cancers and has growth suppressive activities
Deng, Q., & Huang, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207615 · Cited by 110
Increased Expression of EZH2, a Polycomb Group Protein, in Bladder Carcinoma
Arısan, S., Arısan, E. D., Palavan-Ünsal, N., Çaşkurlu, T., Çakır, Ö. O., & Ergenekon, E. (2005) · Urologia Internationalis · doi:10.1159/000087804 · Cited by 99
Kim, J., Kee, H. J., Choe, N., Kim, S., Eom, G.-H., Baek, H. J., Kook, H. Y., Kook, H., & Seo, S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.02130-07 · Cited by 98
PRDM5 Identified as a Target of Epigenetic Silencing in Colorectal and Gastric Cancer
Watanabe, Y., Toyota, M., Kondo, Y., Suzuki, H., Imai, T., Ohe-Toyota, M., Maruyama, R., Nojima, M., Sasaki, Y., Sekido, Y., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0305 · Cited by 89
Skawran, B., Steinemann, D., Weigmann, A., et al. (2008) · Modern Pathology · doi:10.1038/modpathol.3800998 · Cited by 87
Effects of rearrangement and allelic exclusion of JJAZ1 / SUZ12 on cell proliferation and survival
Li, H., Ma, X., Wang, J., Koontz, J. I., Nucci, M. R., & Sklar, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709986104 · Cited by 86
Alterations of the CxxC domain preclude oncogenic activation of mixed-lineage leukemia 2
Bach, C., Mueller, D., Buhl, S., García-Cuéllar, M.-P., & Slany, R. K. (2008) · Oncogene · doi:10.1038/onc.2008.443 · Cited by 86
MMSET is overexpressed in cancers: Link with tumor aggressiveness
Kassambara, A., Klein, B., & Moreaux, J. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.12.093 · Cited by 77
Yatsenko, S. A., Brundage, E. K., Roney, E. K., Cheung, S. W., Chinault, A. C., & Lupski, J. R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp114 · Cited by 77
Caudell, D. L., Zhang, Z., Chung, Y. J., & Aplan, P. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3749 · Cited by 77
Identification of Smyd4 as a Potential Tumor Suppressor Gene Involved in Breast Cancer Development
Hu, L., Zhu, Y. T., Qi, C., & Zhu, Y.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4097 · Cited by 76
Clinical significance of enhancer of zeste homolog 2 expression in colorectal cancer cases
Mimori, K., Ogawa, K., Okamoto, M., Sudo, T., Inoue, H., & Mori, M. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2004.11.001 · Cited by 73
MEIS1 and HOXA7 genes in human acute myeloid leukemia
Afonja, O., Smith, J. E., Jr., Cheng, D. M., Goldenberg, A. S., Amorosi, E. L., Shimamoto, T., Nakamura, S., Ohyashiki, K., Ohyashiki, J. H., Toyama, K., et al. (2000) · Leukemia Research · doi:10.1016/s0145-2126(00)00059-x · Cited by 67
Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia
Cerveira, N., Correia, C., Dória, S., Bizarro, S., Rocha, P., Gomes, P., Torres, L. M. M., Norton, L., Borges, B. S., Castedo, S. M. M. J., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2403104 · Cited by 67
Frequent epigenetic inactivation of RIZ1 by promoter hypermethylation in human gastric carcinoma
Oshimo, Y., Oue, N., Mitani, Y., Nakayama, H., Kitadai, Y., Yoshida, K., Chayama, K., & Yasui, W. (2004) · International Journal of Cancer · doi:10.1002/ijc.20090 · Cited by 66
Lin, Y.-H., Kakadia, P. M., Chen, Y., Li, Y.-Q., Deshpande, A. J., Buske, C., Zhang, K.-L., Zhang, Y., Xu, G.-L., & Bohlander, S. K. (2009) · Blood · doi:10.1182/blood-2009-03-209395 · Cited by 64
Unraveling the epigenetic code of cancer for therapy
Smith, L. T., Otterson, G. A., & Plass, C. (2007) · Trends in Genetics · doi:10.1016/j.tig.2007.07.005 · Cited by 64
Recurrent Inactivation of the PRDM1 Gene in Primary Central Nervous System Lymphoma
Courts, C., Montesinos‐Rongen, M., Brunn, A., Bug, S., Siemer, D., Hans, V., Blümcke, I., Klapper, W., Schaller, C., Wiestler, O. D., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31817dd02d · Cited by 63
Taketani, T., Taki, T., Nakamura, H., Taniwaki, M., Masuda, J., & Hayashi, Y. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2008.12.008 · Cited by 55
RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma
Lal, G., Padmanabha, L., Smith, B. J., Nicholson, R. M., Howe, J. R., O'Dorisio, M. S., & Domann, F. E. (2006) · Cancer · doi:10.1002/cncr.22325 · Cited by 52
Mechanisms predisposing to childhood overgrowth and cancer
Rahman, N. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.04.007 · Cited by 50
Epigenetic therapy of leukemia: An update
Jain, N., Rossi, A., & Garcia‐Manero, G. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.006 · Cited by 49
Zhao, W., Liu, Y., Zhang, Q., Wang, L., Lebœuf, C., Zhang, Y., Ma, J., García, J. F., Song, Y., Li, J., et al. (2008) · Blood · doi:10.1182/blood-2007-08-108654 · Cited by 41
Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas
Li, J., Yin, C., Okamoto, H., Mushlin, H. M., Balgley, B. M., Lee, C. S., Yuan, K. C., Ikejiri, B. L., Gläsker, S., Vortmeyer, A. O., et al. (2008) · Neuro-Oncology · doi:10.1215/15228517-2007-036 · Cited by 40
Starza, R. L., Gorello, P., Rosati, R., Riezzo, A., Veronese, A., Ferrazzí, E., Martelli, M. F., Negrini, M., & Mecucci, C. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20103 · Cited by 37
Reid, A. G., & Nacheva, E. P. (2003) · Leukemia · doi:10.1038/sj.leu.2403162 · Cited by 36
Preferential loss of a polymorphic RIZ allele in human hepatocellular carcinoma
Fang, W., Piao, Z. H., Buyse, I. M., Simón, D., Sheu, J., Perucho, M., & Huang, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1667 · Cited by 36
Kolomietz, E., Marrano, P. M., Yee, K. W. L., Thai, B., Braude, I., Kolomietz, A., Chun, K., Minkin, S., Kamel‐Reid, S., Minden, M. D., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402969 · Cited by 34
Piao, G., Piao, W., He, Y., Zhang, H. H., Wang, G. Q., & Piao, Z. H. (2008) · PubMed · doi:10.14670/hh-23.1171 · Cited by 29
Blimp1 is limiting for transformation in a mouse plasmacytoma model
D’Costa, K., Emslie, D., Metcalf, D., Smyth, G. K., Karnowski, A., Kallies, A., Nutt, S. L., & Corcoran, L. M. (2009) · Blood · doi:10.1182/blood-2008-08-172866 · Cited by 22
(1999) · doi:10.1002/(sici)1097-0215(19991112)83:4<541::aid-ijc17>3.0.co;2-f
Cited by
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
Current state of melanoma diagnosis and treatment
Davis, L. E., Shalin, S. C., & Tackett, A. J. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2019.1640032 · Cited by 922
Molecular mechanisms and potential functions of histone demethylases
Kooistra, S. M., & Helin, K. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3327 · Cited by 878
Self-citationMLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L
Bernt, K. M., Zhu, N., Sinha, A. U., Vempati, S., Faber, J., Krivtsov, A. V., Feng, Z., Punt, N., Daigle, A., Bullinger, L., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.010 · Cited by 870
Large non-coding RNAs: missing links in cancer?
Huarte, M., & Rinn, J. L. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq353 · Cited by 484
Metadata
- Authors
- Albert, M., & Helin, K.
- Venue
- Seminars in Cell & Developmental Biology
- Publisher
- Elsevier BV
- Published
- 2010-04
- Volume
- 21
- Issue
- 2
- Pages
- 209-220
- ISSN
- 1084-9521 (ISSN-L)
- OpenAlex
- W2043206390
- Cited by
- 306
- References
- 160
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.